BACKGROUND: While carbon monoxide (CO) is a known toxin, it is now recognised that CO is also an important signalling molecule involved in physiology and pathophysiology. AIMS: To summarise our current understanding of the role of endogenous CO in the regulation of gastrointestinal physiology and pathophysiology, and to potential therapeutic applications of modulating CO. METHODS: This review is based on a comprehensive search of the Ovid Medline comprehensive database and supplemented by our ongoing studies evaluating the role of CO in gastrointestinal physiology and pathophysiology. RESULTS: Carbon monoxide derived from haem oxygenase (HO)-2 is predominantly involved in neuromodulation and in setting the smooth muscle membrane potential, while CO derived from HO-1 has anti-inflammatory and antioxidative properties, which protect gastrointestinal smooth muscle from damage caused by injury or inflammation. Exogenous CO is being explored as a therapeutic agent in a variety of gastrointestinal disorders, including diabetic gastroparesis, post-operative ileus, organ transplantation, inflammatory bowel disease and sepsis. However, identifying the appropriate mechanism for safely delivering CO in humans is a major challenge. CONCLUSIONS: Carbon monoxide is an important regulator of gastrointestinal function and protects the gastrointestinal tract against noxious injury. CO is a promising therapeutic target in conditions associated with gastrointestinal injury and inflammation. Elucidating the mechanisms by which CO works and developing safe CO delivery mechanisms are necessary to refine therapeutic strategies.
BACKGROUND: While carbon monoxide (CO) is a known toxin, it is now recognised that CO is also an important signalling molecule involved in physiology and pathophysiology. AIMS: To summarise our current understanding of the role of endogenous CO in the regulation of gastrointestinal physiology and pathophysiology, and to potential therapeutic applications of modulating CO. METHODS: This review is based on a comprehensive search of the Ovid Medline comprehensive database and supplemented by our ongoing studies evaluating the role of CO in gastrointestinal physiology and pathophysiology. RESULTS:Carbon monoxide derived from haem oxygenase (HO)-2 is predominantly involved in neuromodulation and in setting the smooth muscle membrane potential, while CO derived from HO-1 has anti-inflammatory and antioxidative properties, which protect gastrointestinal smooth muscle from damage caused by injury or inflammation. Exogenous CO is being explored as a therapeutic agent in a variety of gastrointestinal disorders, including diabetic gastroparesis, post-operative ileus, organ transplantation, inflammatory bowel disease and sepsis. However, identifying the appropriate mechanism for safely delivering CO in humans is a major challenge. CONCLUSIONS:Carbon monoxide is an important regulator of gastrointestinal function and protects the gastrointestinal tract against noxious injury. CO is a promising therapeutic target in conditions associated with gastrointestinal injury and inflammation. Elucidating the mechanisms by which CO works and developing safe CO delivery mechanisms are necessary to refine therapeutic strategies.
Authors: Inja Lim; Simon J Gibbons; Gregory L Lyford; Steven M Miller; Peter R Strege; Michael G Sarr; Suvro Chatterjee; Joseph H Szurszewski; Vijay H Shah; Gianrico Farrugia Journal: Am J Physiol Gastrointest Liver Physiol Date: 2004-08-19 Impact factor: 4.052
Authors: Nina Grosser; Aida Abate; Stefanie Oberle; Hendrik J Vreman; Phyllis A Dennery; Jan C Becker; Thorsten Pohle; Daniel S Seidman; Henning Schröder Journal: Biochem Biophys Res Commun Date: 2003-09-05 Impact factor: 3.575
Authors: Adil E Bharucha; Kyoung Moo Choi; Jessica J Saw; Simon J Gibbons; Gianrico F Farrugia; David A Carlson; Alan R Zinsmeister Journal: Neurogastroenterol Motil Date: 2014-07-29 Impact factor: 3.598
Authors: A E Bharucha; S L Daley; P A Low; S J Gibbons; K M Choi; M Camilleri; J J Saw; G Farrugia; A R Zinsmeister Journal: Neurogastroenterol Motil Date: 2016-06-09 Impact factor: 3.598
Authors: Katarzyna Magierowska; Marcin Magierowski; Magdalena Hubalewska-Mazgaj; Juliusz Adamski; Marcin Surmiak; Zbigniew Sliwowski; Slawomir Kwiecien; Tomasz Brzozowski Journal: PLoS One Date: 2015-10-13 Impact factor: 3.240
Authors: Kyoung Moo Choi; Simon J Gibbons; Lei Sha; Arthur Beyder; Pieter-Jan Verhulst; Gianluca Cipriani; Jessica E Phillips; Anthony J Bauer; Tamas Ordog; Jon J Camp; Xin Ge; Adil E Bharucha; David R Linden; Joseph H Szurszewski; Purna C Kashyap; Gianrico Farrugia Journal: Cell Mol Gastroenterol Hepatol Date: 2016-04-23
Authors: Carmela Nacci; Margherita Fanelli; Maria Assunta Potenza; Valentina Leo; Monica Montagnani; Maria Antonietta De Salvia Journal: World J Gastroenterol Date: 2016-11-14 Impact factor: 5.742
Authors: Marcin Magierowski; Katarzyna Magierowska; Jakub Szmyd; Marcin Surmiak; Zbigniew Sliwowski; Slawomir Kwiecien; Tomasz Brzozowski Journal: Dig Dis Sci Date: 2016-08-19 Impact factor: 3.199